Deanna L. Lane, M.D.
Department of Breast Imaging, Division of Diagnostic Imaging
About Dr. Deanna L. Lane
Dr. Deanna L. Lane is a Professor of Diagnostic Radiology in the Department of Breast Imaging at The University of Texas MD Anderson Cancer Center. She obtained her medical degree in 1999 from The University of Texas Health Science Center at Houston Medical School. From 2000-2004, she pursued her residency training in diagnostic radiology at the Medical College of Virginia, followed by a fellowship in breast imaging at MD Anderson. She joined the breast imaging faculty at MD Anderson in 2006. She is board certified in radiology and a member of the Society of Breast Imaging. She is involved in the clinical teaching of residents and fellows, has authored peer-reviewed articles and book chapters on breast imaging topics, and serves as Associate Editor for the journal BMC Cancer.
Read More
Present Title & Affiliation
Primary Appointment
Professor, Department of Breast Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Imaging techniques for the locoregional staging of breast cancer
Ultrasound assessment of regional lymph nodes in breast cancer patients
Imaging assessment of tumor response to chemotherapy
Clinical Interests
Breast cancer staging
Multimodality breast imaging: Mammography, Tomosynthesis, Ultrasound, MRI
Image-guided breast biopsies and procedures
Education & Training
Degree-Granting Education
| 1999 | The University of Texas Health Science Center at Houston, Houston, Texas, US, MD |
| 1995 | Trinity University, San Antonio, Texas, US, Biology, BS |
Postgraduate Training
| 2005-2006 | Clinical Fellowship, Breast Imaging, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2000-2004 | Clinical Residency, Residency in Diagnostic Radiology, Medical College of Virginia, Richmond, Virginia |
| 1999-2000 | Clinical Internship, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas |
Board Certifications
| 2004 | American Board of Radiology |
Experience & Service
Academic Appointments
Associate Professor, Department of Diagnostic & Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, 2020 - 2022
Associate Professor, Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2022
Associate Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2019
Assistant Professor, Department of Diagnostic & Interventional Imaging, The University of Texas Medical School at Houston, Houston, TX, 2007 - 2020
Assistant Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012
Assistant Professor, Virginia Commonwealth University Medical Center of Virginia, Richmond, VA, 2004 - 2005
Administrative Appointments/Responsibilities
Director of Trainee Education, Co-Director of Breast Imaging Department Education, Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Fellowship Program Director, Department of Breast Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2024
Fellowship Program Director, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2019
Breast Imaging Section Scheduler Director, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2016
Other Appointments/Responsibilities
Clinical Competency Committee, Department of Diagnostic Interventional Imaging, University of Texas Medical School at Houston, Houston, TX, 2013 - 2016
Institutional Committee Activities
Member, Academic Review Committee, 2020 - Present
Member, COVID Recovery Task Force, 2020 - Present
Member, Main Campus Breast Imaging Clinical Rotation Management Committee, 2016 - Present
Member, CME Advisory Committee, 2011 - 2015
Professional Memberships
Selected Presentations & Talks
National Presentations
- 2022. DCE-MRI for early prediction of excellent response versus chemoresistance in triple negative breast cancer (scientific poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2022. Multi-parametric MRI-based radiomics models from tumor and peritumoral regions as potential predictors of treatment response to neoadjuvant systemic therapy in triple negative breast cancer patients (scientific poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2022. A pre-operative dynamic contrast enhanced MRI-based radiomics models as predictors of treatment response after neoadjuvant systemic therapy in triple negative breast cancer patients (scientific poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2022. Longitudinal DCE-MRI radiomic models for early prediction of response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients (scientific poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2022. Deep learning using pre-treatment MRIs and clinical information for prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer. Conference. 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2022. Early prediction of chemoresistance versus excellent response in triple negative breast cancer patients with DCE-MRI. Conference. 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2022. Multi-parametric MRI-based radiomics models for early neoadjuvant systemic treatment response prediction in triple negative breast cancer (TNBC) (scientific poster). Conference. 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2022. Development of a combined model for early prediction of pathologic complete response (pCR) in triple negative breast cancer (TNBC) undergoing neoadjuvant therapy (NAT). Conference. 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. Prediction of response to neoadjuvant systemic therapy in triple negative breast cancer using baseline tumor MRI characteristics and imaging patterns of response (poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2021. Quantitative molecular breast imaging for early prediction of neoadjuvant systemic therapy response in locally advanced breast cancer patients (poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2021. Integrated model for early prediction of neoadjuvant systemic therapy response in triple negative breast cancer (spot-light poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2021. Deep learning for early prediction of neoadjuvant chemotherapy response in triple negative breast cancers (poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2021. Radiomics model based on magnetic resonance image compilation (MagIC) as early predictor of pathologic complete response to neoadjuvant systemic therapy in triple-negative breast cancer (spot-light poster). Conference. San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2021. Early prediction of chemoresistance versus excellent response in triple negative breast cancer patients (TNBC) with DCE-MRI (scientific poster). Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. A composite model for pathologic complete response (pCR) prediction in triple negative breast cancer (TNBC) (scientific poster). Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. A thoracic radiologist’s guide to identification and management of mammary findings on chest CT (education exhibit). Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. Prediction of pathologic complete response in triple negative breast cancer using baseline tumor MRI characteristics and patterns of response during neoadjuvant chemotherapy (poster). Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. Immunogenic response and abnormal axillary node morphology in triple negative breast cancer patients (scientific poster). Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2021. Prediction of pathological complete response to neoadjuvant systemic therapy of triple negative breast cancers via deep learning. Conference. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2020. Volumetric changes on longitudinal dynamic contrast enhanced MR imaging (DCE-MRI) as an early treatment response predictor to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients (poster). Conference. San Antonio Breast Cancer Symposium (virtual event). San Antonio, TX, US.
- 2020. Assessment of early response to neoadjuvant systemic therapy (NAST) of triple-negative breast cancer (TNBC) using chemical exchange saturation transfer (CEST) MRI: a pilot study (poster). Conference. San Antonio Breast Cancer Symposium (virtual event). San Antonio, TX, US.
- 2020. Radiomic phenotypes from dynamic contrast-enhanced MRI (DCE-MRI) parametric maps for early prediction of response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients (poster). Conference. San Antonio Breast Cancer Symposium (virtual event). San Antonio, TX, US.
- 2020. BI-RADS ultrasound lexicon descriptors and tumor-infiltrating lymphocytes in triple negative breast cancer. Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. Comparison of chemical exchange saturation transfer (CEST) MRI acquisition and analysis for early neoadjuvant systemic therapy (NAST) treatment response assessment in triple negative breast cancer (TNBC) (scientific poster). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. Reliability of pharmacokinetic (PK) parameters by DCE-MRI for prediction of neoadjuvant systemic treatment (NAST) response in triple negative breast cancer (TNBC) patients: a comparison of three analysis methods (scientific poster). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. Radiomic features of quantitative apparent diffusion coefficient (ADC) maps from peritumoral regions (PTRs) as predictors of early treatment response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. High risk breast cancer screening (education exhibit). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. Longitudinal MR imaging findings in triple negative breast cancer (TNBC) patients undergoing neoadjuvant systemic therapy (NAST) stratified by tumor infiltrating lymphocytes (TIL) levels (scientific poster). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. Radiomic phenotypes from ultrafast dynamic contrast enhanced (DCE) MRI for prediction of the treatment response to neoadjuvant systemic therapy (NAST) of triple negative breast cancer (TNBC) (scientific poster). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2020. Assessment of early response to neoadjuvant systemic therapy (NAST) in triple-negative breast cancer (TNBC) using chemical exchange saturation transfer (CEST) MRI: pilot study (scientific poster). Conference. 106th Annual Meeting and Scientific Assembly of the Radiological Society of North America (virtual event). Chicago, IL, US.
- 2019. Quantitative apparent diffusion coefficient (ADC) radiomics of tumor and peritumoral regions as potential predictors of treatment response to neoadjuvant chemotherapy (NACT) in triple negative breast cancer (TNBC) patients. Conference. Forty-second Annual CTRC-AACR San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2019. Precision imaging: early ultrasound evaluation (US) to identify excellent responders to neoadjuvant chemotherapy (NAC) in patients (pts) with triple negative breast cancer (TNBC). Conference. 105th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2019. Radiomics of quantitative apparent diffusion coefficient (ADC) from fibroglandular tissue (FGT) for prediction of tumor infiltrating lymphocytes (TIL) levels and neoadjuvant chemotherapy treatment (NACT) response in triple negative breast cancer (TNBC). Conference. Forty-second Annual CTRC-AACR San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2019. Quantitative tumor volumes by fast dynamic contrast enhanced (DCE) MRI predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NACT) in triple negative breast cancer (TNBC). Conference. 105th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2019. Tumor necrosis at baseline dynamic contrast enhanced (DCE) MRI for prediction of neoadjuvant chemotherapy treatment (NACT) response in triple negative breast cancer (TNBC) patients. Conference. 105th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2019. Predicting pathologic complete response with ultrasound tumor characteristics in triple negative breast cancer patients. Conference. 105th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2019. Precision imaging: early ultrasound evaluation (US) identifies excellent responders to neoadjuvant chemotherapy (NAC) in patients (pts) with triple negative breast cancer (TNBC). Conference. American Society of Clinical Oncology. Chicago, IL, US.
- 2018. Early ultrasound evaluation for prediction of treatment response to neoadjuvant chemotherapy in triple negative breast cancer patients (poster). Conference. Forty-first Annual CTRC-AACR San Antonio Breast Cancer Symposium. San Antonio, TX, US.
- 2018. Can mid-treatment ultrasound in triple negative breast cancer patients predict residual pathologic disease in the axillary nodes?. Conference. 104th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2018. Do triple negative breast cancers have characteristic imaging features according to androgen receptor and vimentin status?. Conference. 104th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2018. Impact of metaplastic histology (MpBC) in triple-negative breast cancer (TNBC) patients (pts) receiving neoadjuvant systemic therapy (NAST). Conference. American Society of Clinical Oncology. Chicago, IL, US.
- 2018. A sheep in wolf's clothing - imaging assessment of multiple intraductal breast papillomas. Conference. 118th American Roentgen Ray Society Annual Meeting. Washington, DC, US.
- 2016. Computer-aided detection (CAD) for synthesized mammography: does it perform the same as CAD for full-field digital mammography?. Conference. 102nd Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2016. Breast MRI guided biopsy workshop. Invited. 102nd Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2016. Synthesized mammography (SM) versus full field digital mammography (FFDM): a comparison of lesion detection by radiologists. Conference. 102nd Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2014. Diagnostic breast tomosynthesis: should we dispense of conventional diagnostic mammography views? (poster). Conference. 100th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2014. Tomosynthesis-guided breast biopsy: nuts and bolts. Conference. 100th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2011. The role of MRI in the management of patients with newly diagnosed ductal carcinoma in situ. Conference. 97th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2010. The significance of residual mammographic calcifications after neoadjuvant therapy. Conference. 96th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2010. Monitor zooming and detection of microcalcifications on digital screening mammograms. Conference. 110th American Roentgen Ray Society Annual Meeting. San Diego, CA, US.
- 2009. Digital screening mammography soft copy interpretation times: normal is quicker. Conference. 109th American Roentgen Ray Society Annual Meeting. Boston, MA, US.
- 2008. Where have all the seconds gone?. Conference. Annual Meeting of the Society for Imaging Informatics in Medicine. Seattle, WA, US.
- 2003. Evaluation of deployment accuracy of radiopaque markers used in stereotactic breast biopsy. Conference. 89th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2003. Meeting the challenge: diagnosing multifocal and multicentric breast cancer, CME exhibit. Conference. 89th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
- 2003. Missed breast cancers: test your skills of observation, CME exhibit. Conference. 89th Annual Meeting and Scientific Assembly of the Radiological Society of North America. Chicago, IL, US.
Patient Reviews
CV information above last modified April 15, 2025